[Report of the 10th Annual Meeting of the Chinese society of Clinical Oncology].
The 10th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) was held on 19-23 September 2007 in Harbin. The theme of this conference was "putting standard multidisciplinary cancer management into practice" and special reports of standard multidisciplinary management on various cancers were presented. Over 3 500 clinical oncologists and scientists participated in the 2007 CSCO Annual Meeting where more than ten international top experts were invited to exchange valuable experiences with the delegates. The programs consisted of Education Session, Satellite Symposium and Meet the Professor Session. The latest research results were presented as oral presentations and posters at the congress. Several hotspots were particularly highlighted in this report, including innovative radiotherapy and chemotherapy methods, researches on molecular targets and clinical trials of targeted therapy, such as endostatin, volociximab, cetuximab, bevacizumab and temozolomide. The remarkable research results of anti-cancer Chinese medicine, cancer screening and prognosis were also introduced. This article tries to call the attention to some hot topics in the program that are both new and noteworthy, and it may serve as a highlight of this important international cancer research meeting for clinical oncologists and scientists.
Cho
William Chi-Shing
WC
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China; E-mail: chocs@ha.org.hkConference.
D000846:Anniversaries and Special Events; D002681:China; D006801:Humans; D008495:Medical Oncology; D008516:Medicine, Chinese Traditional; D009369:Neoplasms / Q000628:therapy*; D012955:Societies, Medical